Open AccessTwenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial
Author(s) -
Annelie Johansson,
Huma Dar,
Laura van ′t Veer,
Nicholas P. Tobin,
Gizeh PérezTenorio,
Anordenskjöld,
Ulla Johansson,
Johan Hartman,
Lambert Skoog,
Christina Yau,
Christopher C. Benz,
Laura J. Esserman,
Olle Stål,
Bo Nordenskjöld,
Tommy� Fornander,
Linda S. Lindström
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.21.02844
Subject(s) - medicine , goserelin , tamoxifen , breast cancer , hazard ratio , oncology , interim analysis , proportional hazards model , adjuvant therapy , randomized controlled trial , gynecology , cancer , confidence interval
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom